Denali Therapeutics Inc. (DNLI) Earnings Per Share (EPS)
Denali Therapeutics Inc. (DNLI) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2018-12-31 | $0.82 |
| 2019-12-31 | -$2.07 |
| 2020-12-31 | $0.65 |
| 2021-12-31 | -$2.39 |
| 2022-12-31 | -$2.60 |
| 2023-12-31 | -$1.06 |
| 2024-12-31 | -$2.57 |
| 2025-12-31 | -$2.97 |
How DNLI compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| IONS | Ionis Pharmaceuticals Inc. | -$2.38 |
| VSTM | Verastem Inc. | -$3.02 |
| KURA | Kura Oncology Inc. | -$3.18 |
| SNDX | Syndax Pharmaceuticals Inc. | -$3.29 |
| REPL | Replimune Group Inc. | -$3.38 |
These are five companies in the same sector as DNLI with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Denali Therapeutics Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("DNLI")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | DNLI | $25.00 | +0.68% | 1.56M |
| 3 | ||||
| 4 | ||||
| 5 |